Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

CTNI-55. PREDICTIVE FACTORS FOR HIGH GRADE TRANSFORMATION IN BENIGN MENINGIOMAS

View through CrossRef
Abstract OBJECT Meningiomas are generally slow-growing, benign tumors, most of which are classified as WHO Grade I. Rarely, benign meningiomas may recur after surgery with transformation into WHO Grade II atypical meningiomas. As atypical meningiomas are different from benign meningiomas in terms of clinical course, and prognosis, predicting the transformation is important for patient management. The purpose of the study was to investigate the radiological and pathological factors that predict the risk of tumor progression from benign to atypical meningioma. METHOD All patients treated with recurrent meningiomas in whom the tumor showed histopathologically confirmed high grade transformation between 2001 and 2017 were included. To evaluate the predictors for transformation, patients’ medical records for previous benign meningioma before transformation were collected. Each patient was matched with 4 age and sex-matched controls treated with benign meningioma, and were analyzed. RESULTS Fourteen patients with high grade transformation were included. The median time interval of transformation was 63 months (range of 19 – 132). Multivariate analysis indicated that increased mitotic index (OR, 10.409, 95% CI, 1.297–83.549, p=0.027) was significant predictive factor of transformation. And prominent peritumoral edema (OR, 33.822, 95% CI, 0.935–223.688, p=0.054) showed relative risk for transformation. CONCLUSION Increased mitotic index and prominent peritumoral edema may be predictors for high grade transformation of benign meningiomas. Although these tumors do not meet the criteria for atypical meningioma, they may be required more attentive observation and management than other benign meningiomas.
Oxford University Press (OUP)
Title: CTNI-55. PREDICTIVE FACTORS FOR HIGH GRADE TRANSFORMATION IN BENIGN MENINGIOMAS
Description:
Abstract OBJECT Meningiomas are generally slow-growing, benign tumors, most of which are classified as WHO Grade I.
Rarely, benign meningiomas may recur after surgery with transformation into WHO Grade II atypical meningiomas.
As atypical meningiomas are different from benign meningiomas in terms of clinical course, and prognosis, predicting the transformation is important for patient management.
The purpose of the study was to investigate the radiological and pathological factors that predict the risk of tumor progression from benign to atypical meningioma.
METHOD All patients treated with recurrent meningiomas in whom the tumor showed histopathologically confirmed high grade transformation between 2001 and 2017 were included.
To evaluate the predictors for transformation, patients’ medical records for previous benign meningioma before transformation were collected.
Each patient was matched with 4 age and sex-matched controls treated with benign meningioma, and were analyzed.
RESULTS Fourteen patients with high grade transformation were included.
The median time interval of transformation was 63 months (range of 19 – 132).
Multivariate analysis indicated that increased mitotic index (OR, 10.
409, 95% CI, 1.
297–83.
549, p=0.
027) was significant predictive factor of transformation.
And prominent peritumoral edema (OR, 33.
822, 95% CI, 0.
935–223.
688, p=0.
054) showed relative risk for transformation.
CONCLUSION Increased mitotic index and prominent peritumoral edema may be predictors for high grade transformation of benign meningiomas.
Although these tumors do not meet the criteria for atypical meningioma, they may be required more attentive observation and management than other benign meningiomas.

Related Results

Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract Introduction Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Cardiac troponin is a strong prognostic biomarker for patients admitted with heart failure
Cardiac troponin is a strong prognostic biomarker for patients admitted with heart failure
Abstract Background Cardiac troponin T (cTnT) and I (cTnI) are strong prognostic biomarkers in several diseases and play a key r...
Altered O-linked glycosylation in benign and malignant meningiomas
Altered O-linked glycosylation in benign and malignant meningiomas
Background Changes in protein glycosylation have been reported in various diseases, including cancer; however, the consequences of altered glycosylation in meningiomas remains unde...
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
Objectives The research is to find the related risk factors that may lead to PPCM through analysing and summarising the general clinical characteristics of PPCM p...
The specificity of cardiac troponin elevations for myocardial infarction declines with age
The specificity of cardiac troponin elevations for myocardial infarction declines with age
Abstract Background Cardiac troponin T (cTnT) and I (cTnI) are the gold standard biomarkers of myocardial infarction (MI). Studi...
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Objective Percutaneous Coronary Intervention (PCI) is a technique of cardiac intervention treatment in revascularisation of coronary vessel. The use of PCI in pat...

Back to Top